Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1549230

Boothbay Fund Management, LLC

Hedge fundFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$5.3B
Reported positions
1,956
Top holdings a year, 3 yrs
+30.3%
Assets under management
$18.0B

Boothbay Fund Management, LLC is a hedge fund that reported 1,956 positions worth $5.3B in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Revolution Medicines Inc (RVMD, 1.6%), Abivax SA (ABVX, 1.4%), Cornerstone Strategic Invest (CLM, 1.0%). A portfolio copying its top holdings returned 30.3% a year over the last 3 years, against 20.4% for the S&P 500.

Boothbay Fund Management, LLC holdings largest 50 of 1,956 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Boothbay Fund Management, LLC 13F holdings
Stock% of 13F valueShare changeReported value
RVMDRevolution Medicines Inc1.6%+6.2%$87.2M
ABVXAbivax SA1.4%+19.1%$75.1M
CLMCornerstone Strategic Invest1.0%-0.1%$50.9M
LQDALiquidia Corporation0.9%-0.4%$49.6M
AMTAmerican Tower Corp0.9%—$46.7M
EQIXEquinix Inc0.9%+1.7%$45.8M
EXELExelixis Inc0.8%+0.0%$43.8M
STXSeagate Technology Hldngs Pl0.8%-54.7%$40.7M
AMZNAmazon Com Inc0.8%-22.5%$40.4M
BPBp PLC0.7%—$36.4M
MMM3m Co0.6%—$33.5M
ADIAnalog Devices Inc0.6%—$32.1M
PCVXVaxcyte Inc0.6%+2.3%$31.1M
DLRDigital Rlty Tr Inc0.6%—$29.4M
SBACSba Communications Corp0.5%-3.5%$29.3M
NVDANvidia Corporation0.5%-21.5%$27.8M
FNDFloor & Decor Hldgs Inc0.5%+13.1%$27.7M
COGTCogent Biosciences Inc0.5%—$26.8M
DOXAmdocs Ltd0.5%+34.2%$26.2M
LRCXLam Research Corp0.5%—$25.6M
CTRECaretrust REIT Inc0.5%—$25.3M
BZHBeazer Homes USA Inc0.5%—$25.2M
APHAmphenol Corp0.5%—$25.2M
NWAXNew Amer Acquisition I Corp0.5%—$24.9M
SHELShell PLC0.4%—$23.8M
CURBCurbline Pptys Corp0.4%—$23.6M
AMEAmetek Inc0.4%+14.4%$23.5M
WWayfair Inc0.4%-5.7%$22.2M
ESTAEstablishment Labs Hldgs Inc0.4%—$21.7M
PGProcter & Gamble Co0.4%—$21.7M
AMATApplied Matls Inc0.4%—$21.5M
FIVEFive Below Inc0.4%+26.8%$21.1M
SMTCSemtech Corp0.4%—$20.6M
ARAntero Resources Corp0.4%+70.7%$20.6M
INGIng Groep N.v.0.4%—$20.4M
MDLZMondelez International0.4%—$20.2M
CBRECbre Group Inc0.4%—$20.2M
AMDAdvanced Micro Devices Inc0.4%—$20.0M
ANETArista Networks Inc0.4%-15.9%$19.8M
RGTIWRIGETTI COMPutING INC0.4%—$19.8M
WBDWarner Bros Discovery Inc0.4%+38.6%$19.8M
CGEMCullinan Therapeutics Inc0.4%-2.7%$19.7M
AHRAmerican Healthcare REIT Inc0.4%—$19.4M
HPEHewlett Packard Enterprise C0.4%-40.9%$19.3M
AXONAxon Enterprise Inc0.4%—$19.2M
CIENCiena Corp0.4%+2.5%$19.1M
OFCCopt Defense Properties0.3%—$18.2M
PZZAPapa Johns Intl Inc0.3%+0.7%$18.2M
BURLBurlington Stores0.3%+20.6%$17.4M
MCDMcdonalds Corp0.3%+16.4%$17.3M

What Boothbay Fund Management, LLC bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Added to

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+35.9% /yr
S&P 500 +20.1%
3 years
+30.3% /yr
S&P 500 +20.4%
5 years
+19.2% /yr
S&P 500 +11.2%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$5.3B1,956
Q1 2026$4.3B1,775
Q4 2025$3.9B1,699
Q3 2025$3.9B1,575
Q2 2025$3.3B1,210
Q1 2025$2.9B1,172
Q4 2024$3.3B1,265
Q3 2024$3.2B1,323
Q2 2024$3.1B1,239
Q1 2024$3.4B1,284
Q4 2023$2.7B1,356
Q3 2023$2.9B1,390

Questions about Boothbay Fund Management, LLC's portfolio

What stocks does Boothbay Fund Management, LLC own?

Boothbay Fund Management, LLC's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 1,956 positions worth $5.3B. The largest are Revolution Medicines Inc (RVMD) at 1.6%, Abivax SA (ABVX) at 1.4%, Cornerstone Strategic Invest (CLM) at 1.0%, Liquidia Corporation (LQDA) at 0.9% and American Tower Corp (AMT) at 0.9%.

What did Boothbay Fund Management, LLC buy last quarter?

In Q2 2026, Boothbay Fund Management, LLC added Antero Resources Corp (AR) (+70.7% shares), Warner Bros Discovery Inc (WBD) (+38.6% shares) and Amdocs Ltd (DOX) (+34.2% shares), compared with its Q1 2026 filing.

What did Boothbay Fund Management, LLC sell last quarter?

In Q2 2026, Boothbay Fund Management, LLC cut from its top 50 Ge Aerospace (GE), cut from its top 50 Mineralys Therapeutics Inc (MLYS), cut from its top 50 Terns Pharmaceuticals Inc (TERN), cut from its top 50 Sable Offshore Corp (SOC), cut from its top 50 Marinemax Inc (HZO), Seagate Technology Hldngs Pl (STX) (-54.7% shares), Hewlett Packard Enterprise C (HPE) (-40.9% shares) and Amazon Com Inc (AMZN) (-22.5% shares), compared with its Q1 2026 filing.

How has Boothbay Fund Management, LLC's portfolio performed?

A portfolio copying Boothbay Fund Management, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +30.3% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +35.9% against +20.1%. Over 5 years: +19.2% a year against +11.2%.

When is Boothbay Fund Management, LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Boothbay Fund Management, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Boothbay Fund Management, LLC manage?

Boothbay Fund Management, LLC reported $18.0B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $5.3B.